The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Treatment for Hairy Cell Leukemia

Added Else et al. as reference 9.

Added text to state that trials are ongoing studying combinations of cladribine plus the monoclonal antibody rituximab.

Relapsed or Refractory Hairy Cell Leukemia

This section was extensively revised.

Back to Top

< Previous Section  |  Next Section >